Platform Expansion - Therapeutic

About Butterfly Biosciences

Butterfly Biosciences is a private, pre-market medical technology company targeting the significant inefficiencies in gynecologic diagnosis and care. Its core innovation is the Butterfly InSights platform, an integrated system that allows non-specialist physicians to perform intrauterine diagnostics and treatments in a single office visit, supported by AI-driven analytics. The company is currently in the development and regulatory phase, with plans to commence commercialization in 2025-2026 and achieve FDA clearance for market entry in 2027, addressing a large market of millions of women presenting with gynecologic conditions annually.

Therapeutic Areas